Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fondaparinux Dosing in Renal Failure
NCT01467583Phase 4Completed
- Sponsor
- Wayne State University
- Start
- Nov 2011
- Primary completion
- Nov 2013
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of fondaparinux in venous thromboembolism (VTE), sponsored by Wayne State University. Started Nov 2011; status: completed.
02
Drugs
fondaparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT01467583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01467583.